Agentix (AGTX) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Agentix (AGTX) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -25.59% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,170.12% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 751.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 99.48% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -53.46% |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 54.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.36% |
| Mar 31, 2026 | 190.54% |
| Dec 31, 2025 | 42.98% |
| Sep 30, 2025 | 46.07% |
| Mar 31, 2025 | 345.17% |
| Dec 31, 2024 | -73.85% |
| Sep 30, 2024 | 85.80% |
| Jun 30, 2024 | 74.90% |
| Mar 31, 2024 | 99.07% |
| Nov 30, 2019 | 93.98% |
| Aug 31, 2019 | -324.63% |
| May 31, 2019 | -497.94% |
| Feb 28, 2019 | -315.89% |
| Nov 30, 2018 | -607.81% |
| Aug 31, 2018 | 98.10% |
| May 31, 2018 | -85.47% |
| Feb 28, 2018 | 131.58% |
| Nov 30, 2017 | -92.82% |